Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Olive

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Genome Research|February 8, 2020
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinomaSwati Venkat, Arwen A Tisdale, Johann R Schwarz, et al.
Cancer Research|March 19, 2009
Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse modelJessica A Bertout, Shetal A Patel, Benjamin H Fryer, et al.
Cancers|December 24, 2021
Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor MicroenvironmentSai Preethi Nakkina, Sarah B Gitto, Veethika Pandey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal AdenocarcinomaAndrew Cannon, Christopher M Thompson, H Carlo Maurer, et al.
Cancer Research|September 16, 2024
Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here?Eileen S Carpenter, Debora Barbosa Vendramini-Costa, Marie C Hasselluhn, et al.
Annals of Clinical and Laboratory Science|October 24, 2012
SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and miceReka Szigeti, Stephanie A Pangas, Dorottya Nagy-Szakal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2022
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinomaBeatriz Parejo-Alonso, Alba Royo-García, Pilar Espiau-Romera, et al.
Annals of the Rheumatic Diseases|June 12, 1999
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single componentsM Dougados, B Combe, A Cantagrel, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug"Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto, et al.
Digestion|May 21, 2016
Proteomic Analysis in Esophageal Eosinophilia Reveals Differential Galectin-3 Expression and S-NitrosylationCarla M Davis, Girish Hiremath, John E Wiktorowicz, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Genome Research|February 8, 2020
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinomaSwati Venkat, Arwen A Tisdale, Johann R Schwarz, et al.
Cancer Research|March 19, 2009
Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse modelJessica A Bertout, Shetal A Patel, Benjamin H Fryer, et al.
Cancers|December 24, 2021
Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor MicroenvironmentSai Preethi Nakkina, Sarah B Gitto, Veethika Pandey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal AdenocarcinomaAndrew Cannon, Christopher M Thompson, H Carlo Maurer, et al.
Cancer Research|September 16, 2024
Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here?Eileen S Carpenter, Debora Barbosa Vendramini-Costa, Marie C Hasselluhn, et al.
Annals of Clinical and Laboratory Science|October 24, 2012
SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and miceReka Szigeti, Stephanie A Pangas, Dorottya Nagy-Szakal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2022
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinomaBeatriz Parejo-Alonso, Alba Royo-García, Pilar Espiau-Romera, et al.
Annals of the Rheumatic Diseases|June 12, 1999
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single componentsM Dougados, B Combe, A Cantagrel, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug"Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto, et al.
Digestion|May 21, 2016
Proteomic Analysis in Esophageal Eosinophilia Reveals Differential Galectin-3 Expression and S-NitrosylationCarla M Davis, Girish Hiremath, John E Wiktorowicz, et al.
Pageof 13